With the recent FDA approval of the first siRNA‐derived therapeutic, RNA interference
(RNAi)‐mediated gene therapy is undergoing a transition from research to the clinical …

Nanosystems have shown encouraging outcomes and substantial progress in the areas of
drug delivery and biomedical applications. However, the controlled and targeted delivery of …

Bacterial resistance to antibiotics has made it necessary to resort to using antibacterial drugs
that have considerable toxicities. Here, we show that conjugation of vancomycin-loaded …

In the past two decades, porous silicon (PSi) has attracted increasing attention for its
potential biomedical applications. With its controllable geometry, tunable nanoporous …

The sustained extensive research on graphene and its derivatives in the last decade
portrayed its significance in the field of material science and carved its own niche in …

The incidence of adverse effects and pathogen resistance encountered with small molecule
antibiotics is increasing. As such, there is mounting focus on immunogene therapy to …

Targeting gene-based therapeutics to the brain is a strategy actively sought to treat
Alzheimer's disease (AD). Recent findings discovered the role of apolipoprotein E (ApoE) …

Graphene oxide has been used in different fields of nanomedicine as a manager of drug
delivery due to its inherent physical and chemical properties that allow its use in thin films …

Ischemic stroke (IS) is one of the leading causes of death and disability resulting in
inevitable burden globally. Ischemic injury initiates cascade of pathological events …

The complexity of the nervous system structure and function, and its slow regeneration rate,
makes it more difficult to treat compared to other tissues in the human body when an injury …